リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Medium-Term Impact of the Coronavirus Disease 2019 Pandemic on the Practice of Percutaneous Coronary Interventions in Japan」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Medium-Term Impact of the Coronavirus Disease 2019 Pandemic on the Practice of Percutaneous Coronary Interventions in Japan

Watanabe, Shusuke Shin, Jung-ho Morishita, Tetsuji Takada, Daisuke Kunisawa, Susumu Imanaka, Yuichi 京都大学 DOI:10.5551/jat.63194

2022.11.01

概要

Aims: Declines in cardiovascular diseases during the first surge of coronavirus disease 2019 (COVID-19) have been reported. With the repeating surges of COVID-19, we aim to investigate the medium-term impact of the COVID-19 pandemic on the practice of percutaneous coronary interventions (PCIs). Methods: We performed a descriptive analysis of rates of PCIs, utilizing administrative data in Japan. Changes in the proportion of severe cases and in-hospital mortality since the start of the COVID-19 pandemic were investigated using interrupted time series (ITS) analyses. Results: From April 2018 to February 2021, 38, 696 and 28, 585 cases of elective and emergency PCIs, respectively, were identified. The rates of PCIs decreased during the first and third COVID-19 surges. The ratios of monthly rates of elective PCIs to that in the corresponding months during the previous 2 years were 50.3% in May 2020 and 76.1% in January 2021. The decrease in rates of emergency PCIs was smaller than that of elective PCIs. The ITS analyses did not identify any significant changes in the proportion of severe cases and in-hospital mortality. Conclusions: We found that the impacts of COVID-19 on PCIs were larger in the first surge than in the subsequent and larger in the elective than in the emergency; this continued over the medium-term. During the COVID-19 pandemic, in-hospital mortality of cases undertaking emergency PCIs did not change.

この論文で使われている画像

参考文献

1) Islam N, Shkolnikov VM, Acosta RJ, Klimkin I, Kawachi I, Irizarry RA, Alicandro G, Khunti K, Yates T, Jdanov DA, White M, Lewington S, Lacey B: Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries. BMJ, 2021; 373: n1137

2) Hale T, Angrist N, Goldszmidt R, Kira B, Petherick A, Phillips T, Webster S, Cameron-Blake E, Hallas L, Majumdar S, Tatlow H: A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nat Hum Behav, 2021; 5: 529-538

3) Bontempi E: The europe second wave of COVID-19 infection and the Italy “strange” situation. Environ Res, 2021; 193: 110476

4) Morishita T, Takada D, Shin J, Higuchi T, Kunisawa S, Imanaka Y: Trends, Treatment Approaches, and In-Hospital Mortality for Acute Coronary Syndrome in Japan During the Coronavirus Disease 2019 Pandemic. J Atheroscler Thromb, Published online 2021: 1-11

5) Braiteh N, Rehman W ur, Alom M, Skovira V, Breiteh N, Rehman I, Yarkoni A, Kahsou H, Rehman A: Decrease in acute coronary syndromepresentations during the COVID-19pandemic in upstate New York. Am Heart J, 2020; 226: 147-151

6) Filippo O De, D’Ascenzo F, Angelini F, Bocchino PP, Conrotto F, Saglietto A, Secco GG, Campo G, Gallone G, Verardi R, Gaido L, Iannaccone M, Galvani M, Ugo F, Barbero U, Infantino V, Olivotti L, Mennuni M, Gili S, Infusino F, Vercellino M, Zucchetti O, Casella G, Giammaria M, Boccuzzi G, Tolomeo P, Doronzo B, Senatore G, Marra WG, Rognoni A, Trabattoni D, Franchin L, Borin A, Bruno F, Galluzzo A, Gambino A, Nicolino A, Giachet AT, Sardella G, Fedele F, Monticone S, Montefusco A, Omedè P, Pennone M, Patti G, Mancone M, Ferrari GM De: Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy. N Engl J Med, 2020; 383: 85-88

7) Frankfurter C, Buchan TA, Kobulnik J, Lee DS, Luk A, Mcdonald M, Ross HJ, Alba AC: Reduced Rate of Hospital Presentations for Heart Failure During the COVID-19 Pandemic in Toronto, Canada. Can J Cardiol, 2020; 36: 1680-1684

8) Boriani G, Palmisano P, Guerra F, Bertini M, Zanotto G, Lavalle C, Notarstefano P, Accogli M, Bisignani G, Forleo GB, Landolina M, D’Onofrio A, Ricci R, De Ponti R: Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing). Intern Emerg Med, 2020; 15: 1445-1456

9) Wu J, Mamas MA, de Belder MA, Deanfield JE, Gale CP: Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic. J Am Coll Cardiol, 2021; 77: 1141-1143

10) Solomon MD, Nguyen-Huynh M, Leong TK, Alexander J, Rana JS, Klingman J, Go AS: Changes in Patterns of Hospital Visits for Acute Myocardial Infarction or Ischemic Stroke During COVID-19 Surges. Jama, Published online 2021: E1-E3

11) Haldane V, De Foo C, Abdalla SM, Jung A-S, Tan M, Wu S, Chua A, Verma M, Shrestha P, Singh S, Perez T, Tan SM, Bartos M, Mabuchi S, Bonk M, McNab C, Werner GK, Panjabi R, Nordström A, Legido-Quigley H: Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries. Nat Med, Published online 2021

12) Ministry of Health, Labour, and Welfare: Domestic situation of COVID-19. Accessed [June 9, 2021]. https://www.mhlw.go.jp/stf/covid-19/kokunainohasseijoukyou. html

13) Cabinet Secretariat: Emergency Declaration. Accessed [September 9, 2021]. https: //corona.go.jp/emergency/

14) Japanese Government: Report of interventions during the emergency declaration regarding novel coronavirus infections. Published 2020. Accessed [August 26, 2021]. https: //corona.go.jp/news/pdf/kinkyujitaisengen_ houkoku0604.pdf

15) Yoneoka D, Shi S, Nomura S, Tanoue Y, Kawashima T, Eguchi A, Matsuura K, Makiyama K, Uryu S, Ejima K, Sakamoto H, Taniguchi T, Kunishima H, Gilmour S, Nishiura H, Miyata H: Assessing the regional impact of Japan’s COVID-19 state of emergency declaration: A population-level observational study using social networking services. BMJ Open, 2021; 11: 1-11

16) Nagano H, Takada D, Shin J, Morishita T, Kunisawa S: Hospitalization of mild cases of community-acquired pneumonia decreased more than severe cases during the COVID-19 pandemic. Int J Infect Dis, 2021; 106: 323-328

17) Shin JH, Takada D, Morishita T, Lin H, Bun S, Teraoka E, Okuno T, Itoshima H, Nagano H, Kishimoto K, Segawa H, Asami Y, Higuchi T, Minato K, Kunisawa S, Imanaka Y: Economic impact of the first wave of the COVID-19 pandemic on acute care hospitals in Japan. PLoS One, 2020; 15: 1-11

18) Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H: Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol, 2017; 27: 476-482

19) Ono Y, Taneda Y, Takeshima T, Iwasaki K, Yasui A: Validity of Claims diagnosis codes for cardiovascular diseases in diabetes patients in Japanese administrative database. Clin Epidemiol, 2020; 12: 367-375

20) Dagenais GR, Lu J, Faxon DP, Bogaty P, Adler D, Fuentes F, Escobedo J, Krishnaswami A, Slater J, Frye RL, the BARI 2D Study Group: Prognostic Impact of the Presence and Absence of Angina on Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Stable Coronary Artery Disease: Results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes). J Am Coll Cardiol, 2013; 61: 702-711

21) Khot UN, Jia G, Moliterno DJ, Lincoff AM, Khot MB, Harrington RA, Eric J. Topol M: Prognostic Importance of Physical Examination for Heart Failure in Non– ST-Elevation Acute Coronary Syndromes The Enduring Value of Killip Classification. JAMA, 2003; 290: 2174-2181

22) Yasuda Y, Ishiguchi H, Ishikura M, Yoshida M, Imoto K, Sonoyama K, Kawabata T, Okamura T, Endo A, Kobayashi S, Tanabe K, Yano M, Oda T: Incidence and Demographic Trends for Acute Coronary Syndrome in a Non-Epidemic Area During the Coronavirus Disease Pandemic in Japan - A 2-Institutional Observational Study -. Circ Reports, 2021; 3: 95-99

23) Bhatt AS, Moscone A, Mcelrath EE, Varshney AS, Claggett BL, L. D, Bhatt, Januzzi JL, Butler J, Adler DS, Solomon SD, Vaduganathan M: Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID- 19 Pandemic. J Am Coll Cardiol, 2020; 76: 280-288

24) Metzler B, Siostrzonek P, Binder RK, Bauer A, Reinstadler SJ: Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: The pandemic response causes cardiac collateral damage. Eur Heart J, 2020; 41: 1852-1853

25) The Japanese Circulation Society; Recommendation to maintain healthcare system for circulation diseases during the Covid-19 pandemic (revised in June). Published 2020. Accessed [February 9, 2021]. https: //www.j-circ.or.jp/ topics_classification/covid-19/

26) Mizuno A, Matsumoto C, Yoneoka D, Kishi T, Ishida M, Sanada S, Fukuda M, Saito Y, Yamauchi-Takihara K, Tsutsui H, Fukuda K, Komuro I, Node K: Cardiology Department Practices in the First Wave of the Coronavirus Disease Pandemic - A Nationwide Survey in Japan by the Japanese Circulation Society -. Circ Reports, 2021; 3: 137-141

27) Ranney ML, Griffeth V, Jha AK: Critical Supply Shortages — The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic. N Engl J Med, 2020; 382: e41

28) Ishii H, Amano T, Yamaji K, Kohsaka S, Yokoi H, Ikari Y: Implementation of Percutaneous Coronary Intervention during the COVID-19 Pandemic in Japan - Nationwide Survey Report of the Japanese Association of Cardiovascular Intervention and Therapeutics for Cardiovascular Disease -. Circ J, 2020; 84: 2185-2189

29) Nakamura K: Japanese Medical Facilities Maintained the Quality of Medical Care for Acute Coronary Syndrome during the First Wave of the Coronavirus Disease 2019 Pandemic in Japan. J Atheroscler Thromb, Published online 2021: 1-2

30) Yoshimoto T, Shiozawa M, Koge J, Inoue M, Koga M, Ihara M, Toyoda K: Evaluation of Workflow Delays in Stroke Reperfusion Therapy: A Comparison between the Year-Long Pre-COVID-19 Period and the with- COVID-19 Period. J Atheroscler Thromb, Published online 2021: 1-13

31) Kwok CS, Gale CP, Curzen N, De Belder MA, Ludman P, Lüscher TF, Kontopantelis E, Roebuck C, Denwood T, 1580 Burton T, Hains J, Deanfield JE, Mamas MA: Impact of the COVID-19 pandemic on percutaneous coronary intervention in England: Insights from the british cardiovascular intervention society pci database cohort. Circ Cardiovasc Interv, Published online 2020: 210-221

32) Kite TA, Ladwiniec A, Owens CG, Chase A, Shaukat A, Mozid AM, O’Kane P, Routledge H, Perera D, Jain AK, Palmer N, Hoole SP, Egred M, Sinha MK, Cahill TJ, Candilio L, Anantharam B, Byrne J, Walsh SJ, McEntegart M, Kean S, Siddique L, Budgeon C, Curzen N, Berry C, Ludman P, Gershlick AH: Outcomes following PCI in CABG candidates during the COVID-19 pandemic: The prospective multicentre UK-ReVasc registry. Catheter Cardiovasc Interv, 2021: 1-9

33) De Luca G, Cercek M, Jensen LO, Vavlukis M, Calmac L, Johnson T, Roura i Ferrer G, Ganyukov V, Wojakowski W, von Birgelen C, Versaci F, Ten Berg J, Laine M, Dirksen M, Casella G, Kala P, Díez Gil JL, Becerra V, De Simone C, Carrill X, Scoccia A, Lux A, Kovarnik T, Davlouros P, Gabrielli G, Flores Rios X, Bakraceski N, Levesque S, Guiducci V, Kidawa M, Marinucci L, Zilio F, Galasso G, Fabris E, Menichelli M, Manzo S, Caiazzo G, Moreu J, Sanchis Forés J, Donazzan L, Vignali L, Teles R, Bosa Ojeda F, Lehtola H, Camacho-Freiere S, Kraaijeveld A, Antti Y, Boccalatte M, Martínez-Luengas IL, Scheller B, Alexopoulos D, Uccello G, Faurie B, Gutierrez Barrios A, Wilbert B, Cortese G, Moreno R, Parodi G, Kedhi E, Verdoia M: Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry. Cardiovasc Diabetol, 2020; 19: 1-13

34) Erol MK, Kayıkçıoğlu M, Kılıçkap M, Güler A, Yıldırım A, Kahraman F, Can V, İnci S, Baysal SS, Er O, Zeybey U, Kafkas Ç, Yayla Ç, Arın CB, Aktaş İ, Yalçın AA, Genç Ö, Cosgun M, Inanir M, Yalçin OY, Gunes Y, Kurt IH, Asoglu R, Erdol MA, Cetin M, Ertem AG, Ornek E, Yılmaz Oztekin GM, Genc A, Gitmez M, Aksuyek S, Ari H, Gazi E, Akray A, Deveci OS, Ozturk O, Candemir A, Yavuzgil O, Bakirci EM, Degirmenci H, Fedai H, Besli F, Ince O, Hancıoglu E, Oflar E, Akurk IF, Çaglar NT, Aylin Yamac Halac İCH, Kalyoncuoglu M, Ceneli D, Danisman N, Karatas M, Kirma C, Can C, Dogan AC, Ateslioguz A, Durak F, Sinan UY, Kücükokur M, Ozdogan O, Aksu E, Dagli M, Ozkan E, Simsek Z, Sabanoğlu C, Sen T, Astarcioglu MA, Tigen MK, Sunbul M, Arslan A, Celik A, Akkus O, Alsancak Y, Dural M, Mert KU, Kose N, Kiliç ID, Ogutveren MM, Emlek N, Kocayigit I, Yenerçag M, Yanik A, Dursun I, Çitrakoglu OF, Altay S, Aladag N, Sarikaya R, Sipas A, Tüner H, Tuncer M, Duz R, Ungan I: Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: A nationwide study. Anatol J Cardiol, 2020; 24: 334-342

35) OECD: The health impact of COVID-19 in regions. Published 2020. Accessed [August 31, 2021]. https: // www.oecd-ilibrary.org/sites/5442b5fc-en/index. html?itemId=/content/component/5442b5fc-en

36) Mohammad MA, Koul S, Olivecrona GK, Matthias G, Tydén P, Rydberg E, Scherstén F, Alfredsson J, Vasko P, Omerovic E, Angerås O, Fröbert O, Calais F, Völz S, Ulvenstam A, Venetsanos D, Yndigegn T, Oldgren J, Sarno G, Grimfjärd P, Persson J, Witt N, Ostenfeld E, Lindahl B, James SK, Erlinge D: Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic. 2020: 1812-1818

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る